Back to search

Article

A co-formulation of Interferons alpha2b and gamma distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG

2022-12-20

Abstract excerpt

<title>Abstract</title><p><bold>Background</bold>HeberFERON is a co-formulation of α2b and γ interferons, based on their synergism, which has shown its clinical superiority over individual interferons in basal cell carcinomas. In glioblastoma (GBM), HeberFERON has displayed promising preclinical and clinical results. This led us to design a microarray experiment aimed at identifying the molecular mechanisms involv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e2fde8b2-1c4a-5400-a6ca-f5064fdd4769
DOI
10.21203/rs.3.rs-2369826/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A co-formulation of Interferons alpha2b and gamma distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MGDOI 10.21203/rs.3.rs-2369826/v1
Select a neighboring publication to make it the new centre.